EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Follow-Up Period Affects the Association between Serum 25-Hydroxyvitamin D Concentration and Incidence of Dementia, Alzheimer’s Disease, and Cognitive Impairment

William B Grant iD

Nutrients · 2024

DOI: 10.3390/nu16183211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von William B Grant. Beteiligte Einrichtung: Sunlight, Nutrition, and Health Research Center, 1745 Pacific Ave., Suite 504, San Francisco, CA 94109, USA. Hauptthemen laut MEDLINE: Vitamin D, Alzheimer Disease, Cognitive Dysfunction, Dementia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bio-Tech Pharmacal Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Vitamin D’s effect on risk health outcomes is often evaluated using prospective cohort studies. For vitamin D, risk ratios (RRs) are based on health outcomes with respect to serum 25-hydroxyvitamin D [25(OH)D] concentrations measured at time of enrollment. Serum 25(OH)D concentrations vary over time, thereby diluting the effect of 25(OH)D for long follow-up periods. Inverse relationships between RR and follow-up period have been reported for all-cause mortality rate and cancer incidence rates. Here, the effect for neurological outcomes is evaluated.

Methods

The analysis examines how follow-up period affected results from nine cohort studies of all-cause dementia, six studies of Alzheimer’s disease, and nine for cognitive impairment with respect to vitamin D deficiency.

Results

For all-cause dementia, Alzheimer’s disease, and cognitive impairment, respectively, the linear regression fits are RR = 2.9 − 0.14 × years, r = 0.73, p = 0.02; RR = 2.9 − 0.14 × years, r = 0.69, p = 0.13; and RR = 1.8 − 0.066 × years, r = 0.72, p = 0.03. The regression fit to RR for the shortest follow-up period for each outcome is considered the best estimate of vitamin D deficiency’s effect on risk. Those values are approximately twice that found by averaging all RRs without considering the effect of follow-up period.

Conclusions

Vitamin D’s effect on risk of neurological conditions is inversely correlated with mean follow-up period in prospective cohort studies. This effect should be considered in the design and analysis of such studies. Additional studies should also be conducted regarding raising serum 25(OH)D concentrations to reduce risk of brain function decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DAlzheimer DiseaseCognitive DysfunctionDementiaVitamin D DeficiencyHumansIncidenceFollow-Up StudiesMaleFemaleAgedProspective StudiesRisk Factors

Stichwörter der Autor:innen

Alzheimer’s diseasecognitive impairmentdementiafollow-up periodneurological conditionsriskvitamin D deficiency

Substanzen

Vitamin D25-hydroxyvitamin D

Autor:innen und Institutionen

  • Sunlight, Nutrition, and Health Research Center, 1745 Pacific Ave., Suite 504, San Francisco, CA 94109, USA.

ORCID-Profile: William B Grant

Förderung

  • Bio-Tech Pharmacal Inc.

Zitieren

APA

Grant, W. B. (2024). Follow-Up Period Affects the Association between Serum 25-Hydroxyvitamin D Concentration and Incidence of Dementia, Alzheimer’s Disease, and Cognitive Impairment. Nutrients. https://doi.org/10.3390/nu16183211

Vancouver

Grant WB. Follow-Up Period Affects the Association between Serum 25-Hydroxyvitamin D Concentration and Incidence of Dementia, Alzheimer’s Disease, and Cognitive Impairment. Nutrients. 2024. doi:10.3390/nu16183211

BibTeX
@article{Grant2024,
  author = {Grant, William B},
  title = {Follow-Up Period Affects the Association between Serum 25-Hydroxyvitamin D Concentration and Incidence of Dementia, Alzheimer’s Disease, and Cognitive Impairment},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16183211}
}
Kostenlos starten →